 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
Table 1. Characteristics of RCTs and Observational Studies of Hydroxyurea for Treatment of Sickle Cell Disease*
Return to article